Literature DB >> 2331906

Respiratory tract deposition of ultrafine particles in subjects with obstructive or restrictive lung disease.

P J Anderson1, J D Wilson, F C Hiller.   

Abstract

To evaluate the effects of lung disease on deposition of inhaled ultrafine particles (less than 0.1 micron diameter), we measured total respiratory tract deposition of nonhygroscopic particles of 0.02 to 0.24 micron in five subjects with obstructive lung disease and three subjects with restrictive lung disease and compared it with that in ten normal subjects. Deposition was measured as concentration difference of five size fractions in inhaled and exhaled air using an electrical aerosol analyzer. The data showed that deposition of these ultrafine particles was increased in subjects with obstructive lung disease when compared with normal subjects, while it was unchanged in subjects with restrictive lung disease. The increase in deposition in the subjects with obstructive lung disease was significant for particle sizes 0.04 to 0.24 micron. Possible mechanisms for increased deposition in airway obstruction include increased transit time of particles, abnormal expiratory collapse of airways due to flow limitation, and flow perturbations resulting from decreased airway caliber.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2331906     DOI: 10.1378/chest.97.5.1115

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  28 in total

Review 1.  Ultrafine particles.

Authors:  K Donaldson; V Stone; A Clouter; L Renwick; W MacNee
Journal:  Occup Environ Med       Date:  2001-03       Impact factor: 4.402

2.  Gene expression profile in circulating mononuclear cells after exposure to ultrafine carbon particles.

Authors:  Yuh-Chin T Huang; Michael Schmitt; Zhonghui Yang; Loretta G Que; Judith C Stewart; Mark W Frampton; Robert B Devlin
Journal:  Inhal Toxicol       Date:  2010-08       Impact factor: 2.724

Review 3.  Pulmonary applications and toxicity of engineered nanoparticles.

Authors:  Jeffrey W Card; Darryl C Zeldin; James C Bonner; Earle R Nestmann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-18       Impact factor: 5.464

Review 4.  Measurement techniques for respiratory tract deposition of airborne nanoparticles: a critical review.

Authors:  Jakob Löndahl; Winfried Möller; Joakim H Pagels; Wolfgang G Kreyling; Erik Swietlicki; Otmar Schmid
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-10-23       Impact factor: 2.849

5.  Optimal particle size for beta 2 agonist and anticholinergic aerosols in patients with severe airflow obstruction.

Authors:  P Zanen; L T Go; J W Lammers
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

6.  Adopting Clean Fuels and Technologies on School Buses. Pollution and Health Impacts in Children.

Authors:  Sara D Adar; Jennifer D'Souza; Lianne Sheppard; Joel D Kaufman; Teal S Hallstrand; Mark E Davey; James R Sullivan; Jordan Jahnke; Jane Koenig; Timothy V Larson; L J Sally Liu
Journal:  Am J Respir Crit Care Med       Date:  2015-06-15       Impact factor: 21.405

Review 7.  Carbon nanotubes as delivery systems for respiratory disease: do the dangers outweigh the potential benefits?

Authors:  James C Bonner
Journal:  Expert Rev Respir Med       Date:  2011-12       Impact factor: 3.772

8.  Local lung deposition of ultrafine particles in healthy adults: experimental results and theoretical predictions.

Authors:  Robert Sturm
Journal:  Ann Transl Med       Date:  2016-11

9.  Toxicity and environmental risks of nanomaterials: challenges and future needs.

Authors:  Paresh Chandra Ray; Hongtao Yu; Peter P Fu
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2009-01       Impact factor: 3.781

10.  Total deposition of ultrafine particles in the lungs of healthy men and women: experimental and theoretical results.

Authors:  Robert Sturm
Journal:  Ann Transl Med       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.